- Home
- SGHC vs ABVX Comparison
SGHC vs ABVX Comparison
Compare SGHC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGHC | ABVX |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | Guernsey | France |
| Employees | N/A | 69 |
| Industry | Services-Misc. Amusement & Recreation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 7.2B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGHC | ABVX |
|---|---|---|
| Price | $14.56 | $142.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $17.33 | ★ $131.31 |
| AVG Volume (30 Days) | ★ 3.6M | 2.5M |
| Earning Date | 05-11-2026 | 03-23-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.09 | $52.14 |
| Revenue Next Year | $9.73 | $4,132.27 |
| P/E Ratio | $20.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.46 | $7.70 |
| 52 Week High | $14.70 | $148.83 |
Technical Indicators
Market Signals| Indicator | SGHC | ABVX |
|---|---|---|
| Relative Strength Index (RSI) | 66.22 | 70.15 |
| Support Level | $10.28 | $103.42 |
| Resistance Level | N/A | $148.83 |
| Average True Range (ATR) | 0.54 | 7.74 |
| MACD | 0.05 | 5.54 |
| Stochastic Oscillator | 87.78 | 97.18 |
Price Performance
Historical ComparisonAbout SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's four operating segments-Betway, Spin, Jumpman and DGC. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.